Form 8-K - Current report:
SEC Accession No. 0001493152-24-039111
Filing Date
2024-10-02
Accepted
2024-10-02 08:30:41
Documents
39
Period of Report
2024-10-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37432
2 ex99-1.htm EX-99.1 21374
3 ex99-2.htm EX-99.2 10496
4 ex99-1_001.jpg GRAPHIC 730654
5 ex99-1_002.jpg GRAPHIC 1691819
6 ex99-1_003.jpg GRAPHIC 467738
7 ex99-1_004.jpg GRAPHIC 943662
8 ex99-1_005.jpg GRAPHIC 894517
9 ex99-1_006.jpg GRAPHIC 646626
10 ex99-1_007.jpg GRAPHIC 962938
11 ex99-1_008.jpg GRAPHIC 941120
12 ex99-1_009.jpg GRAPHIC 814042
13 ex99-1_010.jpg GRAPHIC 702473
14 ex99-1_011.jpg GRAPHIC 991281
15 ex99-1_012.jpg GRAPHIC 711767
16 ex99-1_013.jpg GRAPHIC 1008135
17 ex99-1_014.jpg GRAPHIC 725852
18 ex99-1_015.jpg GRAPHIC 1081072
19 ex99-1_016.jpg GRAPHIC 953572
20 ex99-1_017.jpg GRAPHIC 964532
21 ex99-1_018.jpg GRAPHIC 821076
22 ex99-1_019.jpg GRAPHIC 691698
23 ex99-1_020.jpg GRAPHIC 813039
24 ex99-1_021.jpg GRAPHIC 623071
25 ex99-1_022.jpg GRAPHIC 921289
26 ex99-1_023.jpg GRAPHIC 358698
27 ex99-2_001.jpg GRAPHIC 23751
  Complete submission text file 0001493152-24-039111.txt   27045003

Data Files

Seq Description Document Type Size
28 XBRL SCHEMA FILE ser-20241002.xsd EX-101.SCH 3042
29 XBRL LABEL FILE ser-20241002_lab.xml EX-101.LAB 34916
30 XBRL PRESENTATION FILE ser-20241002_pre.xml EX-101.PRE 24614
41 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3966
Mailing Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806
Business Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806 (256) 327-9630
Serina Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: AL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38519 | Film No.: 241345361
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)